MedTech Innovator APAC Pitch Event 3 (Online)

Why It Matters

The pitch event funnels cutting‑edge med‑tech startups into a proven accelerator, accelerating funding and market entry for solutions that address billion‑dollar healthcare challenges.

Key Takeaways

• MedTech Innovator APAC is world’s largest healthcare accelerator
• Over 800 alumni raised $11B, 93% still operating or acquired
• 12 startups pitch in chronic disease, AI, surgical tech categories
• Funding rounds sought: $1M to $7.5M for AI, stent, dialysis solutions
• Winners may join four‑month accelerator, kickoff in San Francisco, finals in Singapore

Summary

The MedTech Innovator APAC Pitch Event, streamed online, showcased twelve early‑stage companies tackling chronic disease, cardiology, radiology, neuro‑intervention and surgical innovation. Hosted by Managing Director Frederick Nyberg in Singapore, the session highlighted the accelerator’s scale—over 800 alumni, $11 billion in follow‑on capital and a 93% survival or acquisition rate—and its rigorous selection process, with fewer than 10% of 680 applicants advancing to pitch. Key data points underscored the program’s impact: a four‑month virtual accelerator bookended by in‑person kick‑offs in San Francisco and a grand‑final in Singapore, and corporate partners ranging from Johnson & Johnson to AI‑focused firms. Startups presented a spectrum of solutions, from Aignya Neurotech’s AI‑assisted neuromonitoring platform seeking $1 million, to Eyes of AI’s dental X‑ray diagnostic engine, to Major Medical Devices’ low‑profile axillary aortic stent targeting $7.5 million funding. Notable pitches included Medkarn’s battery‑operated peritoneal dialysis system eliminating bulky consumable logistics, and Neurospheric’s AI‑guided robotic platform designed to minimize invasive brain surgery. Judges—approximately 40 experts from Asia‑Pacific, the U.S., Europe and Australia—were provided with a digital bio‑book to facilitate rapid feedback, and the live audience received concise 60‑second introductions for each venture. The event signals a growing pipeline of med‑tech innovations poised for global scaling, with the most promising firms advancing to the accelerator’s next phase and potentially securing exposure at the San Francisco kickoff. For investors and corporate partners, the cohort offers a curated view of high‑impact technologies that could reshape chronic disease management and surgical care worldwide.

Original Description

Theme: Chronic Disease Management / Cardiology / Radiology / Neurology / Imaging / GI / Next-Gen Surgical / Robotics/ Orthopaedics / Ophthalmology